NVIDIA BioNeMo Framework has been released and is now generally available to download on NGC, enabling researchers to build and deploy generative AI…
Overview
The NVIDIA BioNeMo Framework is a newly released platform that enables researchers to build and deploy generative AI models for drug discovery. It offers managed services, API endpoints, and training frameworks to accelerate the development of AI applications across the drug discovery pipeline.
What You'll Learn
1
How to leverage the BioNeMo Framework for drug discovery applications
2
Why using state-of-the-art models can enhance drug discovery processes
3
How to optimize training workflows for protein and small molecule models
4
When to apply model pipeline and tensor parallelism for scaling
Prerequisites & Requirements
- Understanding of generative AI and drug discovery concepts
- Access to NVIDIA DGX Cloud or compatible infrastructure(optional)
Key Questions Answered
What features does the BioNeMo Framework v1.0 offer?
The BioNeMo Framework v1.0 offers easy data loading, state-of-the-art domain-specific models, optimized scaling recipes, flexible training workflows, and validation-in-the-loop capabilities. These features simplify and accelerate the process of building generative AI models for drug discovery.
How does BioNeMo optimize training for protein and small molecule models?
BioNeMo provides optimized model architectures and tooling for training protein and small molecule LLMs, including models like BioNeMo ESM1, ESM2, MegaMolBART, and ProtT5. These models are designed for various downstream tasks, enhancing the efficiency of drug discovery applications.
What are the benefits of using H100 GPUs with BioNeMo Framework?
Using H100 GPUs with BioNeMo Framework significantly reduces training times, allowing for models like ESM2 to be trained in just 1.2 days for a 650M parameter model and 3.5 days for a 3B parameter model. This efficiency enables researchers to train larger models in shorter time frames.
What is the BioNeMo workflow for training models?
The BioNeMo workflow involves bringing your own data, accessing DGX Cloud Service, selecting a BioNeMo model, and utilizing pretrained models along with data loaders and training scripts. This structured approach facilitates multi-node training and enhances model performance.
Key Statistics & Figures
Training time for ESM2 650M parameter model
1.2 days
Achieved using BioNeMo Framework and 512 H100 GPUs.
Training time for ESM2 3B parameter model
3.5 days
Achieved using BioNeMo Framework and 512 H100 GPUs.
Training time for ESM2 20B parameter model
18.6 days
Achieved using BioNeMo Framework and 512 H100 GPUs.
Technologies & Tools
Framework
Nvidia Bionemo Framework
Used for building and deploying generative AI models in drug discovery.
Cloud Service
Nvidia Dgx Cloud
Provides on-demand infrastructure for optimal throughput performance.
Hardware
H100 Gpus
Used for accelerating training of large models.
Key Actionable Insights
1Utilize the BioNeMo Framework to streamline your drug discovery projects by integrating state-of-the-art AI models.The framework simplifies the entire drug discovery pipeline, enabling faster target identification and lead optimization, which is critical in the competitive pharmaceutical landscape.
2Implement model pipeline and tensor parallelism to maximize training efficiency for large models.These techniques allow for the distribution of model layers across multiple GPUs, significantly improving throughput and reducing training costs, especially for models exceeding 1B parameters.
3Leverage the pre-trained checkpoints available in BioNeMo for rapid development of domain-specific applications.Using validated checkpoints can save time and resources, allowing researchers to focus on fine-tuning models for specific tasks rather than starting from scratch.
Common Pitfalls
1
Failing to properly configure hyperparameters can lead to suboptimal model performance.
Without careful tuning of hyperparameters, models may not achieve their full potential, resulting in longer training times and less accurate predictions.
Related Concepts
Generative AI In Drug Discovery
Large Language Models (llms)
Nvidia Dgx Cloud Infrastructure
Model Optimization Techniques